Holen Sie sich die Stockscreener-App
11.85
3.95%
0.45
Handel nachbörslich:
11.85
Schlusskurs vom Vortag:
$11.40
Offen:
$11.34
24-Stunden-Volumen:
390.02K
Relative Volume:
1.09
Marktkapitalisierung:
$331.67M
Einnahmen:
$30.43M
Nettoeinkommen (Verlust:
$-18.15M
KGV:
-17.17
EPS:
-0.69
Netto-Cashflow:
$-9.08M
1W Leistung:
+0.42%
1M Leistung:
+2.69%
6M Leistung:
-19.36%
1J Leistung:
+57.58%
1-Tages-Spanne:
$11.20
$11.89
1-Wochen-Bereich:
$11.13
$12.39
52-Wochen-Spanne:
$6.25
$19.22
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Firmenname
Clearpoint Neuro Inc
Sektor
Branche
Telefon
(949) 900-6833
Adresse
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Vergleichen Sie CLPT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
11.85 | 333.53M | 30.43M | -18.15M | -9.08M | -0.69 |
|
ABT
Abbott Laboratories
|
132.03 | 232.62B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.33 | 153.61B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
391.46 | 150.00B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.73 | 112.33B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.28 | 44.99B | 5.54B | 4.18B | 623.10M | 7.00 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-25 | Fortgesetzt | B. Riley Securities | Buy |
| 2023-10-24 | Eingeleitet | Stifel | Buy |
| 2023-02-16 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-04-05 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-03-18 | Eingeleitet | Lake Street | Buy |
| 2020-07-17 | Eingeleitet | B. Riley FBR | Buy |
Alle ansehen
Clearpoint Neuro Inc Aktie (CLPT) Neueste Nachrichten
ClearPoint Neuro (NASDAQ:CLPT) Downgraded by Wall Street Zen to Sell - Defense World
(CLPT) Proactive Strategies - news.stocktradersdaily.com
CLPT SEC FilingsClearpoint Neuro Inc 10-K, 10-Q, 8-K Forms - Stock Titan
ClearPoint Neuro, Inc.(NasdaqCM: CLPT) added to Russell 3000 Growth Index - MarketScreener
(CLPT) Investment Analysis - news.stocktradersdaily.com
ClearPoint Neuro: A Strategic Stake in Gene Therapy's Next Frontier - AInvest
(CLPT) On The My Stocks Page - news.stocktradersdaily.com
ClearPoint Neuro Expands with New Lease Agreement - TipRanks
ClearPoint Neuro (CLPT) Drops 3.58% to April 2025 Low - AInvest
ClearPoint Neuro May 2025 presentation: Enters ’Fast Forward’ phase after Q1 revenue beat - Investing.com
Critical Comparison: T2 Biosystems (NASDAQ:TTOO) vs. ClearPoint Neuro (NASDAQ:CLPT) - Defense World
ClearPoint Neuro (NASDAQ:CLPT) Upgraded by Wall Street Zen to “Hold” Rating - Defense World
Two Sigma Investments LP Makes New $159,000 Investment in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
ClearPoint Neuro director sells $132,800 in stock By Investing.com - Investing.com Canada
ClearPoint Neuro director sells $132,800 in stock - Investing.com
ClearPoint Neuro CEO Joseph Burnett sells shares worth $282k By Investing.com - Investing.com India
ClearPoint Neuro CEO Joseph Burnett sells shares worth $282k - Investing.com
ClearPoint Neuro Inc (CLPT) Shares Down 3.01% on Jun 11 - GuruFocus
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Acquired by Bank of America Corp DE - Defense World
ClearPoint Neuro, Inc. (CLPT): A Bull Case Theory - Insider Monkey
When (CLPT) Moves Investors should Listen - news.stocktradersdaily.com
ClearPoint Neuro Inc (CLPT) Shares Up 5.25% on Jun 4 - GuruFocus
Lake Street says AMT-130 could be ‘significantly impactful’ for ClearPoint - Yahoo Finance
Ameriprise Financial Inc. Has $635,000 Stock Holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
ClearPoint Neuro (CLPT) Anticipates Boost from AMT-130 Partnersh - GuruFocus
ClearPoint Neuro (CLPT) Anticipates Boost from AMT-130 Partnership | CLPT Stock News - GuruFocus
5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil - MSN
Northern Trust Corp Reduces Stock Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
Millennium Management LLC Acquires 13,866 Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
ClearPoint Neuro Inc (CLPT) Trading Down 3.83% on May 28 - GuruFocus
Where are the Opportunities in (CLPT) - news.stocktradersdaily.com
ClearPoint Neuro Approves Key Proposals at Annual Meeting - TipRanks
ClearPoint Neuro Inc. (CLPT) Stock Analysis: A Potential 138% Upside in the Medical Device Sector - DirectorsTalk Interviews
ClearPoint Neuro Updates Director Compensation Plan - TipRanks
Oberland Capital’s Investment in ClearPoint Neuro - Global Legal Chronicle
ClearPoint Neuro targets 15–20 new site activations in 2025 while advancing cell and gene therapy initiatives - MSN
Q2 Earnings Estimate for ClearPoint Neuro Issued By B. Riley - Defense World
ClearPoint Neuro First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
ClearPoint Neuro’s Earnings Call: Growth Amid Challenges - TipRanks
(CLPT) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q1 2025 Earnings Call Transcript - Insider Monkey
ClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Tops Revenue Estimates - MSN
ClearPoint Neuro (CLPT) Confirms Fiscal Year 2025 Revenue Foreca - GuruFocus
ClearPoint Neuro Reports Record Q1 2025 Revenue - TipRanks
ClearPoint Neuro Inc (CLPT) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges - Yahoo Finance
ClearPoint Neuro (CLPT) Reports Strong Q1 Growth and Strategic A - GuruFocus
Clearpoint Neuro earnings missed by $0.06, revenue topped estimates - Investing.com Canada
Earnings call transcript: ClearPoint Neuro’s Q1 2025 revenue beats forecast By Investing.com - Investing.com Canada
ClearPoint Neuro (CLPT) Reports Strong Start to FY25 with Record Revenue | CLPT Stock News - GuruFocus
Clearpoint Neuro Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Finanzdaten der Clearpoint Neuro Inc-Aktie (CLPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.98%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):